期刊文献+

STAT3表达与肿瘤血管生成及放射敏感性关系的研究进展 被引量:10

Role of STAT3 in tumor angiogenesis and radiation sensitivity
下载PDF
导出
摘要 信号转导和转录活化因子3(STAT3)属于STATs家族中重要一员,广泛表达于不同类型的细胞和组织中,并参与细胞生长、增殖、凋亡、恶性转化等生理和病理过程的调控。近年来,STAT3在肿瘤血管生成及放疗敏感性方面的研究日益增多。研究表明STAT3活化后,一方面通过直接调控血管内皮生长因子(VEGF)表达促进血管生成进而产生放疗抗拒;另一方面STAT3通过活化缺氧诱导因子-1α(HIF-1α)间接促进血管生成产生放疗耐受。此外,STAT3还可以直接或通过HIF-1α间接调控细胞周期蛋白D1(Cyclin D1)表达,使细胞周期由G1期快速进入S期,促进细胞增殖,且Cyclin D1与放疗敏感性相关。由此发现,STAT3通过直接和间接两种途径在肿瘤血管生成及放疗抗拒方面发挥作用。本文拟对此方面的相关研究新进展作一综述。 Signal transducer and activator of transcription 3 (STAT3) is an important member of the STAT family of signaling pro- teins. STAT3 is widely expressed in different types of cells and tissues and is involved in many physiological and pathological process- es, including cell growth, proliferation, apoptosis, and malignant transformation. Over recent years, increased attention has been given on the role of STAT3 in tumor angiogenesis and radiation sensitivity. Studies show that on the one hand, following activation, STAT3 promotes angiogenesis by directly regulating the expression of vascular endothelial growth factor and then causes radiation resistance. On the other hand, STAT3 indirectly promotes angiogenesis by activating hypoxia-inducible factor-lct (HIF-1α), thus producing radio- therapy tolerance. Moreover, STAT3 can directly or by HIF-lct indirectly regulate CyclinD1 expression, thus rapidly promoting cell pro- gression through G1 into the S phase of the cell cycle and enhancing cell proliferation. In addition to regulating the cell cycle, CyclinD1 plays a key role in radiation sensitivity. Results suggest that STAT3 plays a role in tumor angiogenesis and radiation resistance via di- rect and indirect mechanisms. In this review, we summarize recent research advances on the role of STAT3 in regulating tumor angio- genesis and radiation sensitivity.
作者 刘彬 蒋晓东
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2015年第10期535-539,共5页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金项目(编号:81472792)资助~~
  • 相关文献

参考文献42

  • 1Jiang XD,Qiao Y,Dai P,et al.Preliminary clinical study of weekly recombinant human endostain as a hypoxic tumor cell radiosensitizer combined with radiotherapy in the treatment of NSCLC[J].Clin Transl Oncol,2012,14(6):465-470.
  • 2Jiang XD,Ding MH,Qiao Y,et al.Study on lung cancer cells expressing VEGFR2 and the impact on the effect of RHES combined with radiotherapy in the treatment of brain metastases[J].Clin Lung Cancer,2014,15(2):23-29.
  • 3Jiang XD,Ding MH,Qiao Y,et al.Recombinant human endostatin combined with rediotherapy in the treatment of brain metastases of non-small cell lung cancer[J].Clin Trans Oncol,2014,16(7):630-636.
  • 4Ebos JM,Kerbel RS.Antiangiogenic therapy:impact on invasion,disease progression,and metastasis[J].Nat Rev Clin Oncol,2011,8(4):210-221.
  • 5Shen YC,Lin ZZ,Hsu CH,et al.Clinical Trials in Hepatocellular Carcinoma:An Update[J].Liver Cancer,2013,2(3-4):345-364.
  • 6Hainsworth JD,Waterhouse DM,Penley WC,et al.Sorafenib and enerolimus in advanced clear cell renal carcinoma:a phase I/II trial of the SCRI Oncology Research Consortium[J].Cancer Invest,2013,31(5):323-329.
  • 7Timme S,Fahrer J,Krohnert U,et al.STAT3 expression,activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas[J].Oncogene,2014,33(25):3256-3266.
  • 8Hodge DR,Hurt EM,farrar WL.The role of IL-6 and STAT3in inflammation and cancer[J].Eur J Cancer,2005,41(16):2502-2512.
  • 9Arulanandam R,Geletu M,Feracci H,et al.Activated Rac1 requires gp130 for Stat3 activation,cell proliferation and migration[J].Exp Cell Res,2010,316(5):875-886.
  • 10Kim HS,Kim SC,Kim SJ,et al.Identification of a radiosensitivity signature using intergrative metaanlaysis of published microarray for NCI-60 cancer cells[J].BMC Genomics,2012,13:348.

同被引文献118

引证文献10

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部